1js3
From Proteopedia
Line 1: | Line 1: | ||
[[Image:1js3.gif|left|200px]] | [[Image:1js3.gif|left|200px]] | ||
- | + | <!-- | |
- | + | The line below this paragraph, containing "STRUCTURE_1js3", creates the "Structure Box" on the page. | |
- | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
- | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
- | + | or leave the SCENE parameter empty for the default display. | |
- | | | + | --> |
- | | | + | {{STRUCTURE_1js3| PDB=1js3 | SCENE= }} |
- | + | ||
- | + | ||
- | }} | + | |
'''Crystal structure of dopa decarboxylase in complex with the inhibitor carbidopa''' | '''Crystal structure of dopa decarboxylase in complex with the inhibitor carbidopa''' | ||
Line 31: | Line 28: | ||
[[Category: Jansonius, J N.]] | [[Category: Jansonius, J N.]] | ||
[[Category: Malashkevich, V N.]] | [[Category: Malashkevich, V N.]] | ||
- | [[Category: | + | [[Category: Carbidopa]] |
- | [[Category: | + | [[Category: Dopa decarboxylase]] |
- | [[Category: | + | [[Category: Parkinson's disease]] |
- | [[Category: | + | [[Category: Vitamin b6]] |
- | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 21:48:57 2008'' | |
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + |
Revision as of 18:49, 2 May 2008
| |||||||||
1js3, resolution 2.25Å () | |||||||||
---|---|---|---|---|---|---|---|---|---|
Ligands: | , , | ||||||||
Activity: | Aromatic-L-amino-acid decarboxylase, with EC number 4.1.1.28 | ||||||||
Related: | 1js6 | ||||||||
| |||||||||
| |||||||||
Resources: | FirstGlance, OCA, RCSB, PDBsum | ||||||||
Coordinates: | save as pdb, mmCIF, xml |
Crystal structure of dopa decarboxylase in complex with the inhibitor carbidopa
Overview
DOPA decarboxylase (DDC) is responsible for the synthesis of the key neurotransmitters dopamine and serotonin via decarboxylation of L-3,4-dihydroxyphenylalanine (L-DOPA) and L-5-hydroxytryptophan, respectively. DDC has been implicated in a number of clinic disorders, including Parkinson's disease and hypertension. Peripheral inhibitors of DDC are currently used to treat these diseases. We present the crystal structures of ligand-free DDC and its complex with the anti-Parkinson drug carbiDOPA. The inhibitor is bound to the enzyme by forming a hydrazone linkage with the cofactor, and its catechol ring is deeply buried in the active site cleft. The structures provide the molecular basis for the development of new inhibitors of DDC with better pharmacological characteristics.
About this Structure
1JS3 is a Single protein structure of sequence from Sus scrofa. Full crystallographic information is available from OCA.
Reference
Structural insight into Parkinson's disease treatment from drug-inhibited DOPA decarboxylase., Burkhard P, Dominici P, Borri-Voltattorni C, Jansonius JN, Malashkevich VN, Nat Struct Biol. 2001 Nov;8(11):963-7. PMID:11685243 Page seeded by OCA on Fri May 2 21:48:57 2008